CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Specifically, CYP2E1 overexpression has long been causally associated with both alcoholic fatty liver disease, as well as non-alcoholic fatty liver disease (NAFLD) [2,3,4,5,6,7,8,9,10,11,12,13,14].